Tianhong Li, M.D., Ph.D.

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    clinical trial
    Date added:
    04/26/2024
    Date updated:
    04/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    RasCal Therapeutics
    Topic:
    clinical trial
    Date added:
    04/26/2024
    Date updated:
    04/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tempus
    Topic:
    clinical trial
    Date added:
    04/26/2024
    Date updated:
    04/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Xilio Therapeutics
    Topic:
    clinical trial
    Date added:
    04/26/2024
    Date updated:
    04/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BMS
    Topic:
    advisory board
    Date added:
    04/26/2024
    Date updated:
    04/26/2024

Pages

Return to Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs